Suppr超能文献

体内 RNAi 治疗药物传递的关键问题。

Critical issues in delivery of RNAi therapeutics in vivo.

机构信息

Department of Biomedical Engineering, Duke University, 136 Hudson Hall Durham, NC 27708, USA.

出版信息

Curr Pharm Biotechnol. 2012 Jun;13(7):1279-91. doi: 10.2174/138920112800624300.

Abstract

RNA interference (RNAi) is a fundamental mechanism of gene regulation and has been harnessed to produce a new class of drugs for treatment of various diseases. A key issue in these applications is how to effectively deliver RNAi therapeutics into target cells. This review is focused on advances in RNA delivery in vivo. To achieve it, novel strategies have been developed to enhance stability of RNA in cells and tissues, overcome barriers to transport of RNA or its carriers in the body, and reduce immunogenicity and cytotoxicity of treatment. Approaches to RNA delivery are divided into three categories in this review: biological, chemical, and physical. Advantages and disadvantages of each method are discussed. At present, effective delivery of RNAi therapeutics in vivo is still a challenge although significant advances have been made in this field.

摘要

RNA 干扰(RNAi)是基因调控的一种基本机制,已被用于开发治疗各种疾病的新型药物。在这些应用中,一个关键问题是如何将 RNAi 治疗剂有效地递送到靶细胞中。本篇综述专注于体内 RNA 递送的进展。为了实现这一目标,已经开发了新的策略来增强 RNA 在细胞和组织中的稳定性,克服 RNA 或其载体在体内运输的障碍,并降低治疗的免疫原性和细胞毒性。在本篇综述中,RNA 递送方法分为生物、化学和物理三类。讨论了每种方法的优缺点。尽管在该领域已经取得了重大进展,但目前在体内有效递送 RNAi 治疗剂仍然是一个挑战。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验